Holger Willenbring
Impact in
- Hepatology top 0.2%
- Liver physiology and pathology
- Genetics top 1%
- Mesenchymal stem cell research
Papers in
-
- Pluripotent Stem Cells Research 13
- Renal and related cancers 4
- Hepatology 21
- Liver physiology and pathology 21
- Co-authors
- Markus Grompe (12 shared papers)Claudia Mitchell (2 shared papers)Milton J. Finegold (6 shared papers)Yassmine Akkari (3 shared papers)Mark P. Foster (2 shared papers)Susan B. Olson (2 shared papers)Yann Malato (8 shared papers)Muhsen Al-Dhalimy (2 shared papers)
- Journals
- Hepatology (9 papers)Journal of Clinical Investigation (4 papers)Proceedings of the National Academy of Sciences (3 papers)Nature (3 papers)Cell stem cell (3 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Holger Willenbring
55 papers receiving 6.0k citations
Holger Willenbring's Hit Papers
Peers
Comparison fields: 5 of 115
- Hepatology 2.0k
- Genetics 816
- Cancer Research 839
- Surgery 2.2k
- Molecular Biology 2.6k
Countries citing papers authored by Holger Willenbring
This map shows the geographic impact of Holger Willenbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Willenbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Willenbring more than expected).
Fields of papers citing papers by Holger Willenbring
This network shows the impact of papers produced by Holger Willenbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Willenbring. The network helps show where Holger Willenbring may publish in the future.
Co-authors
The 25 scholars most cited alongside Holger Willenbring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cell fusion is the principal source of bone-marrow-derived hepatocytes Hit paper breakdown → | 2003 | 1200 |
| 2 | A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice Hit paper breakdown → | 2008 | 426 |
| 3 | 2012 | 362 | |
| 4 | 2011 | 326 | |
| 5 | 2004 | 300 | |
| 6 | 2018 | 210 | |
| 7 | 2006 | 204 | |
| 8 | 2014 | 203 | |
| 9 | 2010 | 203 | |
| 10 | 2014 | 199 | |
| 11 | 2010 | 174 | |
| 12 | 2007 | 161 | |
| 13 | 2019 | 161 | |
| 14 | 2006 | 158 | |
| 15 | 2016 | 147 | |
| 16 | 2010 | 137 | |
| 17 | 2012 | 133 | |
| 18 | 2014 | 133 | |
| 19 | 2016 | 109 | |
| 20 | 2013 | 92 |
About Holger Willenbring
Holger Willenbring is a scholar working on Molecular Biology, Hepatology, Surgery, Epidemiology and Physiology, having authored 55 papers that have together received 6.1k indexed citations. Recurring topics across this work include Liver physiology and pathology (21 papers), Pluripotent Stem Cells Research (13 papers), Pancreatic function and diabetes (13 papers), Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease Diagnosis and Treatment (5 papers), MicroRNA in disease regulation (5 papers), 3D Printing in Biomedical Research (5 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Hepatology (2.0k citations), Genetics (816 citations), Cancer Research (839 citations), Surgery (2.2k citations) and Molecular Biology (2.6k citations). Holger Willenbring has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Markus Grompe, Claudia Mitchell, Milton J. Finegold, Yassmine Akkari, Mark P. Foster, Susan B. Olson, Yann Malato, Muhsen Al-Dhalimy, Yumi Torimaru and Eric Lagasse. Their work appears in journals such as Hepatology, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Nature and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.